-
Big Response to Government’s Low-Cost Insurance Schemes in India
The low-premium life and accident insurance schemes introduced by the government recently have elicited huge response, attracting 11 crore subscribers in just three months.
- Categories
- Health Care
- Region
- South Asia
-
Viewpoint: The Ebola Vaccine We Needed
About 27,000 people in West Africa have been infected with the Ebola virus and more than 11,000 of them have died since the outbreak began last year. Many could have been saved if an effective vaccine had been available. But the world relies on drug companies to create new vaccines and medications, and they have no financial incentive to do so for diseases that mostly affect poor countries. Clearly, the world needs a better mechanism for vaccine development.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Can Microfinance Help Boost Sanitation Coverage?
The time when microfinance was seen as the miracle cure to lift people out of poverty is long gone. The funding crisis in India in 2010 and evidence of mixed impacts from microfinance have contributed to a greater understanding of both its strengths and weaknesses. While microfinance is usually associated with income generation, rather than taps and toilets, growing evidence shows that it could be a solution for funding sanitation facilities in developing countries.
- Categories
- Health Care
- Region
- South Asia
-
Viewpoint: TPP’s Outcome Pivotal for Future of Global Biomedical Innovation
After seven years of wrangling toward the final terms of an ambitious free trade agreement that will join 12 Asia-Pacific nations, only the thorniest of market access and intellectual property issues remain unresolved in the Trans-Pacific Partnership (TPP). Of these, perhaps the most contentious concerns how long pharmaceutical companies should have exclusive intellectual property rights covering the clinical trial data they compile as they develop novel biologic medicines. U.S. negotiators have stood fast in advocating for 12 years of data protection — the standard that Congress enshrined into U.S. law following extensive deliberation — while other TPP parties have sought to limit the regulatory data protection period to as little as five to seven years.
- Categories
- Health Care
- Tags
- public policy
-
Can randomized trials eliminate global poverty?
A new generation of economists is trying to transform global development policy through the power of randomized controlled trials.
- Categories
- Health Care
-
Why drug companies are betting big on ‘pharmerging’ countries
Developing countries like China, Brazil and India will drive nearly half of the growth in drug spending in the near future. Here’s how Big Pharma could play the trend.
- Categories
- Health Care
-
Bill Gates to Narendra Modi: You Need to Generate New Healthcare Models for India
After over a year in power, the Narendra Modi government's decisions to cut federal welfare spending on the poorest of India's 1.25 billion people have come in for a sharp criticism, including from within his cabinet.
- Categories
- Health Care
- Region
- South Asia
-
GE Commits $14.7 Million to Build Healthcare Skills in East Africa
The global health sector, particularly in the developing countries, faces critical workforce shortages. Africa ranks the lowest in the availability of health personnel. Sub-Saharan Africa is home to 12 percent of the world’s population and bears 25 percent of the world’s burden of diseases, but has only three percent of the world’s health workforce.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- impact investing
Subscribe to Our Weekly Newsletter, "NextBillion Notes"
Published each Wednesday, our e-newsletter features NextBillion's latest original articles, along with a selection of news, jobs, bizdev opportunities and events from our recent coverage — and regular conference ticket giveaways.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.